Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Aug;52(8):743-50.
doi: 10.1097/MLR.0000000000000170.

Effect of self-referral on bone mineral density testing and osteoporosis treatment

Affiliations
Randomized Controlled Trial

Effect of self-referral on bone mineral density testing and osteoporosis treatment

Amy H Warriner et al. Med Care. 2014 Aug.

Abstract

Background: Despite national guidelines recommending bone mineral density screening with dual-energy x-ray absorptiometry (DXA) in women aged 65 years and older, many women do not receive initial screening.

Objective: To determine the effectiveness of health system and patient-level interventions designed to increase appropriate DXA testing and osteoporosis treatment through (1) an invitation to self-refer for DXA (self-referral); (2) self-referral plus patient educational materials; and (3) usual care (UC, physician referral).

Research design: Parallel, group-randomized, controlled trials performed at Kaiser Permanente Northwest (KPNW) and Kaiser Permanente Georgia (KPG).

Subjects: Women aged 65 years and older without a DXA in past 5 years.

Measures: DXA completion rates 90 days after intervention mailing and osteoporosis medication receipt 180 days after initial intervention mailing.

Results: From >12,000 eligible women, those randomized to self-referral were significantly more likely to receive a DXA than UC (13.0%-24.1% self-referral vs. 4.9%-5.9% UC, P<0.05). DXA rates did not significantly increase with patient educational materials. Osteoporosis was detected in a greater proportion of self-referral women compared with UC (P<0.001). The number needed to receive an invitation to result in a DXA in KPNW and KPG regions was approximately 5 and 12, respectively. New osteoporosis prescription rates were low (0.8%-3.4%) but significantly greater among self-referral versus UC in KPNW.

Conclusions: DXA rates significantly improved with a mailed invitation to schedule a scan without physician referral. Providing women the opportunity to self-refer may be an effective, low-cost strategy to increase access for recommended osteoporosis screening.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Screening and Randomization CONSORT Diagram
Figure 2
Figure 2
Cumulative incidence of DXA receipt in Kaiser Permanente Northwest (KPNW) (2a) and Kaiser Permanente Georgia (KPG) (2b) after two intervention strategies compared to usual care.
Figure 3
Figure 3
Rates of DXA Testing (3a) and Osteoporosis Prescription Treatment (3b) stratified by Bone Mineral Density and Treatment Groups for Each Study Region. SELF: self-referral without patient educational materials; SELF+DVD: self-referral with patient educational materials; UC: Usual Care. KPNW: Kaiser Permanente Northwest. KPG: Kaiser Permanente Georgia

References

    1. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Bmj. 1996;312(7041):1254–9. - PMC - PubMed
    1. Surgeon General's Report on bone health and osteoporosis. Office of the Surgeon General; Rockville (MD): 2004. 2010/10/15. - PubMed
    1. 2010 Pages http://www.nof.org/sites/default/files/pdfs/NOF_ClinicianGuide2009_v7.pdf.
    1. Lim LS, Hoeksema LJ, Sherin K. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice. Am J Prev Med. 2009;36(4):366–75. - PubMed
    1. Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010;16(Suppl 3):1–37. - PMC - PubMed

Publication types